Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy A Franks

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The British Journal of Ophthalmology|April 12, 2012
Avoidable sight loss from glaucoma: is it unavoidable?Aachal Kotecha, Sofia Fernandes, Catey Bunce, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 24, 2002
Interpreting glaucoma progression by white-on-white perimetryJames C H Tan, Wendy A Franks, Roger A Hitchings
Clinical Therapeutics|June 6, 2006
A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertensionWendy A Franks, Jean P Renard, Ian A Cunliffe, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 16, 2011
Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case seriesAachal Kotecha, Alexander Spratt, Lola Ogunbowale, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The British Journal of Ophthalmology|April 12, 2012
Avoidable sight loss from glaucoma: is it unavoidable?Aachal Kotecha, Sofia Fernandes, Catey Bunce, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 24, 2002
Interpreting glaucoma progression by white-on-white perimetryJames C H Tan, Wendy A Franks, Roger A Hitchings
Clinical Therapeutics|June 6, 2006
A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertensionWendy A Franks, Jean P Renard, Ian A Cunliffe, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 16, 2011
Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case seriesAachal Kotecha, Alexander Spratt, Lola Ogunbowale, et al.
Pageof 1